| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
92,578 |
82,176 |
$8.19M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
49,874 |
45,720 |
$2.97M |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
9,521 |
8,276 |
$1.71M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
17,492 |
16,867 |
$1.07M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
16,937 |
16,159 |
$1.05M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
13,276 |
12,599 |
$786K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
18,093 |
16,885 |
$736K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
27,512 |
25,009 |
$544K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
7,828 |
7,532 |
$470K |
| 87634 |
|
9,488 |
8,765 |
$416K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
16,301 |
14,434 |
$395K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
4,238 |
4,032 |
$389K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
28,407 |
26,336 |
$349K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
7,225 |
6,785 |
$315K |
| 90670 |
|
11,314 |
11,028 |
$271K |
| 90648 |
|
14,555 |
14,043 |
$266K |
| 99460 |
|
3,198 |
2,826 |
$243K |
| 90723 |
|
10,780 |
10,367 |
$209K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
3,416 |
3,037 |
$201K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
3,046 |
2,863 |
$180K |
| 90680 |
|
7,578 |
7,301 |
$148K |
| 90686 |
|
6,365 |
6,187 |
$117K |
| 99173 |
|
30,844 |
29,675 |
$116K |
| 90633 |
|
6,222 |
6,055 |
$116K |
| 90716 |
|
5,545 |
5,385 |
$113K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
10,949 |
10,648 |
$111K |
| 99462 |
|
3,194 |
1,873 |
$107K |
| 90707 |
|
5,408 |
5,282 |
$105K |
| 92551 |
|
22,582 |
21,839 |
$99K |
| 99401 |
|
3,136 |
2,988 |
$90K |
| 54150 |
|
654 |
555 |
$89K |
| 90461 |
|
1,662 |
1,599 |
$88K |
| D1206 |
Topical application of fluoride varnish |
5,071 |
4,969 |
$80K |
| 90651 |
|
3,490 |
3,369 |
$77K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
610 |
566 |
$73K |
| 90671 |
|
3,328 |
3,089 |
$73K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,588 |
6,804 |
$67K |
| 90734 |
|
2,854 |
2,740 |
$62K |
| 83655 |
|
4,457 |
4,288 |
$61K |
| 96127 |
|
14,738 |
14,157 |
$55K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,468 |
3,692 |
$40K |
| 92552 |
|
1,405 |
1,366 |
$37K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
625 |
598 |
$34K |
| 90696 |
|
1,563 |
1,527 |
$29K |
| 99215 |
Prolong outpt/office vis |
232 |
215 |
$28K |
| 90700 |
|
1,504 |
1,459 |
$28K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
309 |
283 |
$26K |
| 90688 |
|
1,471 |
1,400 |
$26K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
218 |
193 |
$24K |
| 90715 |
|
1,252 |
1,189 |
$23K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,000 |
1,894 |
$21K |
| 87807 |
|
2,007 |
1,889 |
$21K |
| 71046 |
Radiologic examination, chest; 2 views |
1,241 |
1,123 |
$21K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,426 |
1,389 |
$19K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,999 |
1,787 |
$17K |
| D0145 |
Oral evaluation for a patient under three years of age |
1,078 |
1,063 |
$17K |
| 80061 |
Lipid panel |
1,262 |
1,186 |
$16K |
| 96161 |
|
7,344 |
6,955 |
$13K |
| 90620 |
|
656 |
636 |
$12K |
| 69210 |
|
492 |
256 |
$12K |
| 90681 |
|
578 |
553 |
$11K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
181 |
167 |
$11K |
| 36416 |
|
33,449 |
30,706 |
$10K |
| 80053 |
Comprehensive metabolic panel |
918 |
858 |
$10K |
| 81003 |
|
2,959 |
2,710 |
$8K |
| 0001A |
|
209 |
207 |
$7K |
| 0002A |
|
195 |
190 |
$7K |
| 90656 |
|
408 |
359 |
$7K |
| 0072A |
|
162 |
162 |
$6K |
| 99464 |
|
119 |
93 |
$6K |
| 0071A |
|
158 |
157 |
$6K |
| 94060 |
|
161 |
151 |
$5K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
276 |
255 |
$5K |
| 86580 |
|
594 |
572 |
$3K |
| 86308 |
|
610 |
551 |
$3K |
| 74018 |
|
156 |
147 |
$3K |
| 82247 |
|
545 |
370 |
$2K |
| 99051 |
|
7,446 |
6,857 |
$2K |
| 85018 |
|
9,864 |
9,569 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
47 |
47 |
$2K |
| 96160 |
|
1,085 |
992 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,297 |
992 |
$1K |
| 99177 |
|
146 |
144 |
$1K |
| 94010 |
|
69 |
68 |
$1K |
| 94664 |
|
101 |
99 |
$902.00 |
| 99383 |
|
15 |
12 |
$770.00 |
| 0081A |
|
12 |
12 |
$480.00 |
| 90685 |
|
12 |
12 |
$237.48 |
| 82947 |
|
42 |
40 |
$160.00 |
| 36415 |
Collection of venous blood by venipuncture |
2,786 |
2,632 |
$149.20 |
| 81025 |
|
44 |
41 |
$119.60 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
97 |
93 |
$41.98 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
31,305 |
30,167 |
$30.00 |
| 91307 |
|
12 |
12 |
$0.00 |
| 91300 |
|
59 |
49 |
$0.00 |